PFE Pfizer to All Time High

If you haven`t bought at my first call, when PFE was $40:

Than you should know that Pfizer’s vaccine with BioNTech SE is on track to be the best-selling drug product on a yearly basis and received backing from a European regulatory panel on Thursday to expand its use into children as young as five.

Still low PE Ratio (TTM) 15.42
Decent Forward Dividend & Yield 1.56 (2.89%)

The stock jumped also on the promise of its antiviral pill!

For me is a Buy even at this level!